维普中文期刊产品整合服务
523篇 您的检索式:作者名="Curran M"
    题名 作者 年代 出处 被引量
1Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations显示文摘Thompson MC Fuller C Hogg TL Dalton J Finkelstein D Lau CC Chintagumpala M Adesina A Ashley DM KeUie SJ Taylor MD Curran T Gajjar A Gilbertson RJ 2006中国神经肿瘤杂志2006,4,1:17
2RTOG 0211:a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients显示文摘PURPOSE: To determine the safety and efficacy of gefitinib,an epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor,in combination with radiation for newly diagnosed glioblastoma(GBM) patients.METHODS AND MATERIALS: Between March 21,2002,and May 3,2004,Radiation Therapy Oncology Group(RTOG) 0211 enrolled 31 and 147GBM patients in the phase 1 and 2 arms,respectively.Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy(RT) and continued post RT for 18 months or until progression.Tissue microarrays from 68 cases were analyzed for EGFR expression.RESULTS: The maximum tolerated dose(MTD) of gefitinib was determined to be 500 mg in patients on non-enzyme-inducing anticonvulsant drugs(non-EIAEDs).All patients in the phase 2 component were treated at a gefitinib dose of 500 mg;patients receiving EIADSs could be escalated to 750 mg.The most common side effects of gefitinib in combination with radiation were dermatologic and gastrointestinal.Median survival was 11.5 months for patients treated per protocol.There was no overall survival benefit for patients treated with gefitinib + RT when compared with a historical cohort of patients treated with RT alone,matched by RTOG recursive partitioning analysis(RPA) class distribution.Younger age was significantly associated with better outcome.Per protocol stratification,EGFR expression was not found to be of prognostic value for gefitinib + RT-treated patients.CONCLUSIONS: The addition of gefitinib to RT is well tolerated.Median survival of RTOG 0211 patients treated with RT with concurrent and adjuvant gefitinib was similar to that in a historical control cohort treated with radiation alone.Chakravarti A Wang M Robins HI Lautenschlaeger T Curran WJ Brachman DG Schultz CJ Choucair A Dolled-Filhart M Christiansen J Gustavson M Molinaro A Mischel P Dicker AP Bredel M Mehta M 2013中国神经肿瘤杂志2013,11,1:8
3蛋白酶和木聚糖酶对育肥猪的生长性能、营养消化率以及粪便气味的影响显示文摘菜籽粕(RSM)和小麦干酒糟及其可溶物(DDGS)作为副产物可应用到猪的日粮中。然而,与小麦和豆粕型日粮相比,RSM和DDGS中含有较高的非淀粉多糖(NSP),其可限制猪对日粮的有效利用。采用2×2因素试验设计研究生长育肥猪饲粮中添加木聚糖酶(0和200mg·kg-1)和蛋白酶(0和200mg·kg-1)对其生长性能、胴体品质、表观回肠消化率、全消化道养分消化率及粪便气体排放的影响及两种酶之间的相互作用。试验1,对猪的生长性能进行评估。将体重为34.2±2.1kg的育肥猪128头随机分配到4个处理组:以DDGS(300g·kg-1)和RSM(210g·kg-1)的基础日粮;基础日粮中添加蛋白酶200mg·kg-1;基础日粮中添加木聚糖酶200mg·kg-1;基础日粮中添加蛋白酶200mg·kg-1和木聚糖酶200mg·k-1。试验1中,在生长育肥-出栏期间(0~出栏),日粮中添加蛋白酶的试验猪较不添加蛋白酶的试验猪相比具有较低的平均日增重(ADG)(P〈0.001)。生长阶段(0—28d),蛋白酶和木聚糖酶对猪的日均采食量(ADFI,P〈0.01)和体重(BW,P〈0.01)的影响存在相互作用。在育肥阶段(28d~出栏),日粮中添加蛋白酶和木聚糖酶的试验猪与仅添加一种没酶的试验猪相比具有较低的ADFI和BW。然而,蛋白酶和木聚糖酶的相互作用在生长期间(0~28d)内并不显著。试验2,选择体重78±2.3kg公猪24只,将其置于代谢笼中进行代谢试验,试验期间按照试验l中的日粮进行饲喂。木聚糖酶和蛋白酶对总能(GE)中的AID存在相互作用(P〈0.05)。与对照组相比,饲粮中添加蛋白酶可以增加GE中的AID,但饲粮中添加两种酶时可降低GE中的AID。饲粮中添加木聚糖酶交不添加木聚糖组相比,猪粪便的臭气排放量降低(598和1306OuE/m3;P〈0.05)。研究表明,蛋白酶可提高GE的AID;木聚糖酶可以减少粪便异味的排放,然而当生长猪育肥以RSM和DDGS为基础饲粮时,两种酶均不能提高其生长性能。O'Shea C J Mc Alpine P O Solan P Curran T Varley P F Walsh A M Doherty J V O 2014饲料博览2014,0,10:4
4Immunochmistry of the Extracellular Matrix显示文摘PESEIOTTA D M CURRAN S OISEN B R 1982Bio Res1982,1,:2
5Experimental mixing study of a yield stress fluid in a laminar stirred tank显示文摘Curran S J Hayes R E Afacan A Williams M C 2000Ind Eng Chem Res2000,39,1:1
6Fine spatialresolution simulated satellite sensor imagery for landcover mapping in the UK显示文摘Aplin P Atkinson P M Curran P J 1999Remote Sensing ofEnvironment1999,68,3:1
7Coffee fermentation and flavor-An intricate and delicate relationship显示文摘Lee L W Cheong M W Curran P 2015Food Chemistry2015,185,1:1
8Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro 显示文摘Horikami S M Curran J Kolakofsky D 1992J Virol1992,66,:1
9Encouraging existing customers to switch to self-service technologies: put a little fun in their lives 显示文摘Curran J M Meuter M L 2007Journal of Marketing Theory and Practice2007,15,4:1
10Estimate canopy chlorophyll concentration from field and airborne spectra显示文摘JAGO R A Cutler M E J Curran P J 1999Remote Sensing Environment1999,68,3:1
11PENDULUM-a guidelinebased approach to the interpretation of STR mixtures显示文摘Bill M Gill P Curran J 2005Forensic Sci Int2005,148,:1
12Comparison of LIMPET contra-rotating wells turbine with theoretical and model test predictions显示文摘FOLLEY M CURRAN R WHITTAKER T 0,,8:1
13Controlling the phenotype andfunction of mesenchymal stem cells in vitro by adhesion tosilanemodified clean glass surfaces 显示文摘Curran J M Chen R Hunt J A 2005Biomaterials2005,26,34:1
14Influence of an interprofessional HIV/AIDS education program on role perception, attitudes and teamwork skills of undergraduate health sciences students显示文摘CURRAN V R MUGFORD J G LAW R M 2005Education for Health (Abingdon England)2005,18,1:1
15The relationship between the biomass of Camerppnoan tropical forests and radiation reflected in middle infrared wavelengths显示文摘BOYD D S FOODY G M CURRAN P J 1999International Journal of Remote Sensing1999,20,5:1
16The relation between re- fitted radiation and yield on the broad balk winter wheat experi- ment显示文摘Ashcroft P M Catt J A Curran P J 1990Int J Remote Sensing1990,11,10:1
17Progress in working towards a more sustainable agri-food industry显示文摘Notarnicola B Hayashi K Curran M A 2012Journal of Cleaner Production2012,28,3:1
18The automorphism group of a split metacyclic p-group 显示文摘BIDWELL J N S CURRAN M J 2006Archiv Der Mathematic2006,87,6:1
19Increased serum and testicular androgen levels in F1 rats with lifetime exposure to soy isoflavones 显示文摘McVey M J Cooke G M Curran I H A 2004Reproductive Toxicology2004,18,5:1
20A Comprehensive Modeling Study of Hydrogen Oxidation显示文摘CONAIRE M CURRAN H J SIMMIE J M 2004International Jour- nal of Chemical Kinetics2004,36,11:1
返回顶部 每页显示:
共27页 首页 上一页 第1页 下一页 末页 /27 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费